Total Raised

$22.82M

Investors Count

13

Multiply Labs Funding, Multiply Labs Valuation & Multiply Labs Revenue

6 Fundings

Multiply Labs's latest funding round was a Series A for $20M on April 14, 2021.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

4/14/2021

Series A

$20M

0

FY undefined

15

3/16/2021

Option/Warrant

$99M

0

FY undefined

10

5/2/2017

Seed VC

$99M

0

FY undefined

10

8/17/2016

Seed

$99M

0

FY undefined

10

1/1/2016

Spinoff / Spinout

0

FY undefined

10

Date

4/14/2021

3/16/2021

5/2/2017

8/17/2016

1/1/2016

Round

Series A

Option/Warrant

Seed VC

Seed

Spinoff / Spinout

Amount

$20M

$99M

$99M

$99M

Investors

Valuation

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

15

10

10

10

10

Multiply Labs Investors

13 Investors

Multiply Labs has 13 investors. Garage Capital invested in Multiply Labs's Series A funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

5/2/2017

4/14/2021

2
Seed VC, Series A (2021)

Venture Capital

Canada

5/2/2017

4/14/2021

2
Seed VC, Series A (2021)

Venture Capital

California

4/14/2021

4/14/2021

1
Series A

Venture Capital

California

00/00/0000

00/00/0000

Casdin Capital

Subscribe to see more

Venture Capital

New York

00/00/0000

00/00/0000

Lux Capital

Subscribe to see more

Venture Capital

New York

First funding

5/2/2017

5/2/2017

4/14/2021

00/00/0000

00/00/0000

Last Funding

4/14/2021

4/14/2021

4/14/2021

00/00/0000

00/00/0000

Investor

Casdin Capital

Lux Capital

Rounds

2
Seed VC, Series A (2021)
2
Seed VC, Series A (2021)
1
Series A

Subscribe to see more

Subscribe to see more

Board Seats

Type

Venture Capital

Venture Capital

Venture Capital

Venture Capital

Venture Capital

Location

Canada

California

California

New York

New York

You May Also Like

O
Ori Biotech

Ori Biotech develops a proprietary, flexible manufacturing platform that closes, automates, and standardizes manufacturing, allowing therapeutics developers to further develop and bring their products from pre-clinical process development to commercial scale manufacturing.

C
Cellares

Cellares is a cell therapy manufacturing technology startup in South San Francisco. Cellares is creating the future of cell therapy manufacturing and accelerating access to life-saving cell therapies. The company is developing a one-of-a-kind solution to overcome the limitations associated with manufacturing cell therapies to make them more affordable and widely available to patients in need. With Cellares' proprietary platform, The Cell Shuttle, biopharma companies, academic research centers and CDMOs will no longer have to compromise by either choosing a manufacturing platform that is semi-automated but lacks workflow flexibility, or one that provides customization but not the end-to-end automation needed to manufacture at scale.

Cellino Logo
Cellino

Cellino is developing an intracellular delivery technique for gene editing applications.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.